Moderna, Inc. (BMV:MRNA)

Sage Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	202,669	333,413	641,050	1,346,048	2,111,061	822,597
Market Cap Growth	-75.80%	-47.99%	-52.38%	-36.24%	156.63%	569.08%
Enterprise Value	75,197	169,902	448,475	1,038,983	1,940,435	761,628
Last Close Price	521.00	856.00	1665.00	3475.87	5200.00	2068.53
PE Ratio	-	-	-	8.25	8.44	-
PS Ratio	3.49	4.95	5.54	3.58	5.58	51.48
PB Ratio	1.14	1.47	2.74	3.61	7.28	16.14
P/TBV Ratio	1.16	1.48	2.76	3.61	7.28	16.14
P/FCF Ratio	-	-	-	15.06	7.72	21.10
P/OCF Ratio	-	-	-	13.85	7.56	20.40
EV/Sales Ratio	1.30	2.52	3.87	2.77	5.12	47.67
EV/EBITDA Ratio	-	-	-	5.45	7.00	-
EV/EBIT Ratio	-	-	-	5.65	7.12	-
EV/FCF Ratio	-1.14	-	-	11.63	7.10	19.54
Debt / Equity Ratio	0.08	0.07	0.09	0.06	0.07	0.09
Debt / EBITDA Ratio	-	-	-	0.12	0.07	-
Debt / FCF Ratio	-	-	-	0.26	0.07	0.12
Asset Turnover	0.22	0.20	0.31	0.76	1.15	0.18
Inventory Turnover	16.52	37.66	13.92	6.02	5.19	-
Quick Ratio	3.56	3.45	3.21	2.35	1.54	1.37
Current Ratio	3.93	3.67	3.43	2.73	1.76	1.44
Return on Equity (ROE)	-27.50%	-28.77%	-28.59%	50.27%	146.08%	-39.99%
Return on Assets (ROA)	-14.77%	-15.14%	-11.96%	23.30%	51.93%	-10.68%
Return on Capital (ROIC)	-17.70%	-18.44%	-14.96%	33.28%	93.06%	-23.21%
Return on Capital Employed (ROCE)	-	-	-	45.00%	85.60%	-
Earnings Yield	-27.01%	-22.25%	-12.43%	12.12%	11.85%	-1.81%
FCF Yield	-32.47%	-25.34%	-10.09%	6.64%	12.95%	4.74%
Buyback Yield / Dilution	-1.05%	-0.52%	8.17%	3.48%	-13.12%	-15.11%

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.